Condition
Pharmacokinetics and Pharmacodynamics
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 1 (3)
Trial Status
Recruiting2
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06601257Phase 1RecruitingPrimary
Vancomycin Dose Optimization in Obesity
NCT06993636Recruiting
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
NCT04684056Unknown
Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
NCT02576353Phase 1CompletedPrimary
Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects
NCT01391663Phase 1CompletedPrimary
Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants
Showing all 5 trials